Picture of Dancann Pharma A/S logo

DANCAN — Dancann Pharma A/S News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Dancann Pharma A/S Says Acquires CannGros ApS

Oct 4 (Reuters) - Dancann Pharma A/S  DANCAN.TE :
    * ACQUIRES CANNGROS APS AND BECOMES MARKET LEADER IN THE
DANISH
MARKET UNDER THE PILOT PROGRAMME WITH MEDICAL CANNABIS
    * UNDER TERMS, OWNERS OF CANNGROS WILL RECEIVE 7 MDKK OF
DANCANN
PHARMA SHARES AT A MARKET PRICE ISSUED AT DKK 3.664 PER SHARE
    * 100%  OF CONSIDERATION SHARES WILL BE SUBJECT TO A 1-YEAR
LOCK-UP PERIOD FROM DATE OF COMPLETION OF TRANSACTION
    * CLOSING OF TRANSACTION ARE SUBJECT TO CUSTOMARY CONDITIONS
AND
CLOSING IS EXPECTED TO TAKE PLACE DURING OCTOBER 2021
    * TRANSACTION ALSO INCLUDES A 6 MDKK PAYABLE IN CASH OVER
TWO
INSTALLMENTS

Source text for Eikon:  ID:nWkr3fhwfW 
Further company coverage:  DANCAN.TE 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Dancann Pharma A/S

See all news